ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs MXN
16.99024
0.00%
Brent Oil
81.295
0.00%
Bitcoin
67,927.82
0.30%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Finch Therapeutics Group Inc (FNCH)

  7. Finch Therapeutics Group Inc (FNCH) Noticias

FNCH

Finch Therapeutics (FNCH)

Finch Therapeutics Group Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:FNCH
FechaHoraFuenteTítuloSímboloCompañía
24/05/202405:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FNCHFinch Therapeutics Group Inc
10/05/202415:45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FNCHFinch Therapeutics Group Inc
13/12/202316:20Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:FNCHFinch Therapeutics Group Inc
11/08/202305:31Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:FNCHFinch Therapeutics Group Inc
28/06/202315:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FNCHFinch Therapeutics Group Inc
23/06/202315:31Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:FNCHFinch Therapeutics Group Inc
09/06/202315:53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FNCHFinch Therapeutics Group Inc
09/06/202306:00GlobeNewswire Inc.Finch Announces Reverse Stock Split of Common StockNASDAQ:FNCHFinch Therapeutics Group Inc
16/05/202315:17Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:FNCHFinch Therapeutics Group Inc
11/05/202315:13Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:FNCHFinch Therapeutics Group Inc
10/05/202306:15Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FNCHFinch Therapeutics Group Inc
10/05/202306:00GlobeNewswire Inc.Finch Therapeutics Reports First Quarter 2023 Financial Results and Provides Business UpdatesNASDAQ:FNCHFinch Therapeutics Group Inc
26/04/202315:05Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:FNCHFinch Therapeutics Group Inc
26/04/202315:02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:FNCHFinch Therapeutics Group Inc
25/04/202315:05GlobeNewswire Inc.Finch Therapeutics Announces Executive Leadership TransitionsNASDAQ:FNCHFinch Therapeutics Group Inc
18/04/202315:01GlobeNewswire Inc.Finch Therapeutics Announces Clinical Collaboration in Ulcerative Colitis with Brigham and Women’s Hospital and Updates to University of Minnesota License AgreementNASDAQ:FNCHFinch Therapeutics Group Inc
14/04/202315:08Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:FNCHFinch Therapeutics Group Inc
23/03/202315:25Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:FNCHFinch Therapeutics Group Inc
23/03/202315:05GlobeNewswire Inc.Finch Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business UpdatesNASDAQ:FNCHFinch Therapeutics Group Inc
24/01/202307:00GlobeNewswire Inc.Finch Therapeutics Announces Decision to Discontinue Phase 3 Trial of CP101 and Focus on Realizing the Value of Its Intellectual Property Estate and Other AssetsNASDAQ:FNCHFinch Therapeutics Group Inc
10/11/202206:00GlobeNewswire Inc.Finch Therapeutics Provides Corporate Updates and Reports Third Quarter 2022 Financial ResultsNASDAQ:FNCHFinch Therapeutics Group Inc
09/11/202207:00GlobeNewswire Inc.Finch Therapeutics to Present at the Jefferies London Healthcare Conference and Evercore ISI HealthCONx ConferenceNASDAQ:FNCHFinch Therapeutics Group Inc
24/10/202207:00GlobeNewswire Inc.Finch Therapeutics Presents PRISM-EXT Biomarker Data at ACG 2022 and Proceeds with Patient Dosing in Phase 3 Trial of CP101 in Recurrent C. Difficile InfectionNASDAQ:FNCHFinch Therapeutics Group Inc
01/09/202207:00GlobeNewswire Inc.Finch Therapeutics Provides Business UpdateNASDAQ:FNCHFinch Therapeutics Group Inc
25/08/202215:30GlobeNewswire Inc.Finch Therapeutics Regains Full Rights to FIN-524 and FIN-525 Targeted Microbiome Product Candidates in Development for IBDNASDAQ:FNCHFinch Therapeutics Group Inc
11/08/202206:00GlobeNewswire Inc.Finch Therapeutics Provides Corporate Updates and Reports Second Quarter 2022 Financial ResultsNASDAQ:FNCHFinch Therapeutics Group Inc
03/06/202205:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:FNCHFinch Therapeutics Group Inc
02/06/202206:00GlobeNewswire Inc.Finch Therapeutics to Participate in Upcoming June Investor ConferencesNASDAQ:FNCHFinch Therapeutics Group Inc
17/05/202207:00GlobeNewswire Inc.Finch Therapeutics to Present at the H.C. Wainwright Global Investment ConferenceNASDAQ:FNCHFinch Therapeutics Group Inc
16/05/202206:00GlobeNewswire Inc.Finch Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial ResultsNASDAQ:FNCHFinch Therapeutics Group Inc
 Showing the most relevant articles for your search:NASDAQ:FNCH

Su Consulta Reciente

AMEX
XLE
Energy Select Sector SPDR
NYSE
KO
Coca Cola
USOTC
BASFY
BASF (QX)
CCOM
OILBRENT
Brent Oil
NASDAQ
TSLA
Tesla
NYSE
MCD
McDonalds
SPI
SP500
S&P 500
NYSE
VZ
Verizon Communications
NYSE
XOM
Exxon Mobil
FX
EURUSD
Euro vs US Dollar
NYSE
AXP
American Express
NASDAQ
AAPL
Apple
CCOM
US500
US 500
USI
USTECH100
US Tech 100
NYSE
JPM
JP Morgan Chase
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados